ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma

Zhang, Xuehua; Wang, Guoyan; Gong, Yujiao; Zhao, Leilei; Song, Ping; Zhang, He; Zhang, Yurui; Ju, Huanyu; Wang, Xiaoyu; Wang, Bin; Ren, Huan*; Zhu, Xiao*; Dong, Yucui*哈尔滨医科大学; 烟台大学; 中山大学; 5
iScience2023-5-19DOI: 10.1016/j.isci.2023.106639
2被引23阅读
引用收藏
分享

摘要

Dual or multi-targets therapy targeting epidermal growth factor receptor variant III (EGFRvIII) and other molecular may relax the constraint for glioblastoma (GBM), putting forward the urgent requirement of finding candidate molecules. Here, the insulin-like growth factor binding protein-3 (IGFBP3) was considered a candidate, whereas the mechanisms of IGFBP3 production remain unclear. We treated GBM cells with exogenous transforming growth factor beta (TGF-beta) to simulate the microenvironment. We found that TGF-beta and EGFRvIII transactivation induced the activation of transcription factor c-Jun, which specifically bound to the promoter region of IGFBP3 through Smad2/3 and ERK1/2 pathways and promoted the production and secretion of IGFBP3. IGFBP3 knockdown inhibited the activation of TGF-b and EGFRvIII signals and the malignant behaviors triggered by them in vitro and in vivo. Collectively, our results indicated a positive feedback loop of p-EGFRvIII/IGFBP3 under administration of TGF-beta, blocking IGFBP3 may be an additional target in EGFRvIII-expressing GBM-selective therapeutic strategy.

学科与关键词

关键词
FACTOR-BINDING PROTEIN-3TUMOR-GROWTHEXPRESSIONEGFRPROGRESSIONACTIVATIONSURVIVALMECHANISMSMIGRATIONPROFILES
相关
加载中…
  • EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-?B/ALDH1A3 Axis
    Shi, Zhong-Fang; Li, Guan-Zhang; Zhai, You; Pan, Chang-Qing; Wang, Di; Yu, Ming-Chen; Liu, Chi; Zhang, Wei; Yu, Xiao-Guang*Genes, 2023, 14(3): 651.被引 3
  • Cancer cell intrinsic TIM-3 induces glioblastoma progression
    Guo, Qing; Shen, Shuai; Guan, Gefei; Zhu, Chen; Zou, Cunyi; Cao, Jingyuan; Cheng, Wen; Xu, Xiaoyan; Yu, Juanhan; Lin, Zhiguo; Wang, Guoli; Chen, Ling; Cheng, Peng*; Wu, Anhua*iScience, 2022, 25(11): 105329.被引 9
  • Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity
    Liu, Yi; Li, Zhongjun; Zhang, Maolei; Zhou, Huangkai; Wu, Xujia; Zhong, Jian; Xiao, Feizhe; Huang, Nunu; Yang, Xuesong; Zeng, Rong; Yang, Lixuan; Xia, Zhibo; Zhang, Nu*NEURO-ONCOLOGY, 2021, 23(5): 743-756.被引 64
查看全部 →

发表信息

论文状态
公开发表
期刊
iScience
发表日期
2023-05-19
卷期
第 26 卷, 第 5 期
页码
106639
DOI
10.1016/j.isci.2023.106639
成果收录
SCIE
资助标注
Shandong Provincial Natural Science Foundation of China [ZR2021MH036]; National Natural Science Foundation of China [81402054, 61902094, 81472367]; Science and Technology Program of Binzhou Medical University [50012304325]

作者

  • Z

    Zhang, Xuehua (第一作者)

    binzhou med univ

  • W

    Wang, Guoyan

    binzhou med univ

查看全部 13 位作者收起作者
  • G

    Gong, Yujiao

    5 · sun yat sen univ

  • Z

    Zhao, Leilei

    binzhou med univ

  • S

    Song, Ping

  • Z

    Zhang, He

    qiqihar med univ

  • Z

    Zhang, Yurui

    binzhou med univ

  • J

    Ju, Huanyu

    harbin med univ

  • W

    Wang, Xiaoyu

  • W

    Wang, Bin

    binzhou med univ

  • R

    Ren, Huan (通讯)

  • Z

    Zhu, Xiao (通讯)

    yantai univ

  • D

    Dong, Yucui (通讯)

    binzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417